StonvexLoading…
StonvexStonvexStonvexCore line items from SHFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.67M | $15.24M | $17.56M | $9.48M |
Operating Income | $-5.40M | $-7.09M | $-20.73M | $-2.20M |
Net Income | $-2.16M | $-48.32M | $-17.28M | $-35.13M |
EPS (Diluted) | $-0.82 | $-17.43 | $-8.12 | $-1.85 |
Total Assets | $17.21M | $13.22M | $67.86M | $99.45M |
Total Liabilities | $8.97M | $25.51M | $33.51M | $94.34M |
Cash & Equivalents | $6.78M | $2.32M | $4.89M | $8.39M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-1.04M | $1.68M |
Shares Outstanding | 2.92M | 2.78M | 2.73M | 23.73M |